retatrutide clinical trial results retatrutide Results: 28.3% Weight Loss Data Drug retatrutide helps people lower

Adults with type 2 diabetes and cancer who used a GLP-1 had a lower risk for death and hospitalization compared with adults who used metformin, according to findings published in The Journal of Clinical Endocrinology &amp

A new study from Norway by Tuominen and colleagues gives us a fresh roadmap for repurposing existing drugs to treat and to potentially modify the course of this disease

At the first day of the 26th SMSNA Annual Fall Scientific Meeting, Dr

Little is known about the association of discontinuation of sodium-glucose cotransporter-2 (SGLT2) inhibitors and glucagon-like peptide-1 receptor agonists (GLP-1 RA) with outcomes in patients with CKD

Sacubitril/valsartan has demonstrated consistent benefits not only in HF with reduced ejection fraction (HFrEF) but also in selected patients with mildly reduced or preserved ejection fraction (HFmrEF/HFpEF), especially women and those with borderline left ventricular ejection fraction, as shown in the Prospective Comparison of ARNI with ACEI to Determine Impact on Global Mortality and Morbidity in Heart Failure (PARADIGM-HF) and Prospective Comparison of ARNI with ARB Global Outcomes in HF With Preserved Ejection Fraction (PARAGON-HF) trials and supported by Indian ARNI PRESERVED study

In Canada, peptides are regulated as prescription medications and should only be administered under the guidance of a licensed healthcare professional